Dissecting the sources of variation in neuronally differentiated iPSC lines through multi-omics analysis
Visser, C. d.; Rahm, L.; Lewerissa, E.; Mijdam, R.; Doornbos, C.; Huang, J.; O'Gorman, L.; Badmus, F.; van Karnebeek, C. D. M.; Faber, C. G.; Verhoeven, J.; van Bokhoven, H.; Kasri, N. N.; Lefeber, D.; 't Hoen, P. A. C.; van Gool, A. J.; Kulkarni, P.
Show abstract
Induced pluripotent stem cells (iPSCs) are widely used as patient-specific disease models, yet substantial unexplained variability in molecular and functional readouts limits their reliability. Here, we systematically investigated the sources of variation in iPSC-derived neurons for three rare genetic disorders: Myotonic Dystrophy Type 1, chromodomain-DNA-helicase-binding protein 2-related disorder and N-acetylneuraminic acid synthase deficiency. This was performed by profiling multi-omics layers: genomics, epigenomics, transcriptomics, proteomics, metabolomics and lipidomics. Our study found that clonal variability was comparable to inter-patient differences and that neuronal differentiation state and nutrient-driven metabolic activity emerged as dominant contributors to variability observed across omics layers. Clonal differences could partly be attributed to stochastic differences in DNA methylation established during reprogramming. By modeling and correcting the observed variation, we improved the detection of disease-associated molecular signatures. Our study provides guidelines for improved study design and data analysis to minimize variability, enabling robust biomarker discovery and reliable iPSC-based disease modeling.
Matching journals
The top 6 journals account for 50% of the predicted probability mass.